Stay updated on CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.

Latest updates to the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Added Revision: v3.3.3 to the history. - Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page shows a minor site version update from v3.2.0 to v3.3.2, with no impact on the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the government funding status notice from the page. The study record content and navigation remain unchanged.SummaryDifference0.4%

- Check64 days agoChange DetectedCompared with the old version, the new version updates several fields in the study record, including Study Status and Recruitment/Contacts-Locations details. This reflects ongoing maintenance and revisions to how the trial is listed and who can participate.SummaryDifference0.1%

- Check93 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference10%

- Check100 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.